InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PMGC Holdings Inc.

ELAB Clue Score37
United States Fiscal year ends December CIK 0001840563
$3.08 -1.44% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.08 −49.51% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Nov 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2022Revenue0.8Net income−1.8EPS, diluted−0.19Fiscal year 2023Revenue1.7 +123.5%Net income−4.3EPS, diluted−0.40Fiscal year 2024Net income−6.2EPS, diluted−4,239.70Fiscal year 2025Revenue0.6Net income−7.7EPS, diluted−382.30
FY2022FY2023FY2024FY2025
Revenue 0.8 1.7 n/a 0.6
Growth +123.5%
Net income −1.8 −4.3 −6.2 −7.7
Growth
EPS, diluted −0.19 −0.40 −4,239.70 −382.30
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2022Gross margin58.4%Net margin−234.9%Fiscal year 2023Gross margin66.2%Net margin−251.2%Free cash flow margin−266.7%Fiscal year 2024Fiscal year 2025Gross margin31.4%Net margin−1,313.0%Free cash flow margin−1,080.5%
FY2022FY2023FY2024FY2025
Gross margin 58.4% 66.2% n/a 31.4%
Net margin −234.9% −251.2% n/a −1,313.0%
Free cash flow margin n/a −266.7% n/a −1,080.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−1.6Fiscal year 2023Operating cash flow−4.6Capital expenditure−0.0Free cash flow−4.6Fiscal year 2024Operating cash flow−5.5Capital expenditure−0.0Free cash flow−5.5Fiscal year 2025Operating cash flow−5.9Capital expenditure−0.4Free cash flow−6.4
FY2022FY2023FY2024FY2025
Operating cash flow −1.6 −4.6 −5.5 −5.9
Capital expenditure n/a −0.0 −0.0 −0.4
Free cash flow n/a −4.6 −5.5 −6.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash1.2Shareholders’ equity1.1Fiscal year 2023Cash3.3Shareholders’ equity3.8Fiscal year 2024Cash4.0Shareholders’ equity6.7Fiscal year 2025Cash5.4Shareholders’ equity7.8
FY2022FY2023FY2024FY2025
Cash 1.2 3.3 4.0 5.4
Shareholders’ equity 1.1 3.8 6.7 7.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.8 1.7 n/a 0.6
Growth +123.5%
0.3 1.7 n/a 0.4
0.4 1.1 n/a 0.2
Growth +153.6%
0.2 0.0 0.1 0.1
1.0 0.3 1.1 2.2
n/a n/a −4.0 −7.7
n/a n/a n/a 0.0
−1.8 −4.3 −6.2 −7.7
Growth
Per share
−0.19 −0.40 −4,239.70 −382.30
−0.19 −0.40 −4,239.70 −382.30
Growth
9.5 0.0 0.0 0.0

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.